Search
for
Sort by
Research 271–300 of 1000+
- Alopecia areata update
- Treatment options for alopecia: an update, looking to the future
- Hidradenitis Suppurativa
- Dissecting folliculitis (dissecting cellulitis) of the scalp: a 66‐patient case series and proposal of classification
- Low-Dose Systemic Methotrexate Therapy for Recalcitrant Alopecia Areata
- Acne in Dark Skin
- Oxidative Stress in Alopecia Areata and its Association with Disease Severity, Treatment and Autoimmunity
- Dermatologic Care of the Transplant Patient
- Alopecia Areata and Alopecia Areata Incognita
- Alopecia Areata
- Comparative Effects of Ustekinumab and Vedolizumab on Alopecia in Ulcerative Colitis: A Systematic Review and Meta-Analysis
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Comparing the Efficiency of Elidel Cream and Elidel Accompanied With Tretinoin Cream in Treatment of Alopecia Areata
- Antiulcer drugs
- Recognition and management of <i>Staphylococcus aureus</i> toxin‐mediated disease
- Interferon in the treatment of cutaneous T-cell lymphoma
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Treatment of Vitiligo With the 308-nm Xenon Chloride Excimer Laser
- Scalp Dysesthesia
- Patients with specific skin disorders who are affected by COVID ‐19: What do experiences say about management strategies? A systematic review
- Adolescent hair loss
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Hair Loss in Children
- Relationship between betacoronaviruses and the endocrine system: a new key to understand the COVID-19 pandemic—A comprehensive review
- Management of hair loss diseases
- Local Corticosteroids for Alopecia Areata: A Narrative Review
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Cutaneous Markers of Disorders Affecting Adult Horses
- Ottawa, Ontario, Canada, February 13–16, 2013